Literature DB >> 21857834

Why should we define and target early Crohn's disease?

Laurent Peyrin-Biroulet1.   

Abstract

Entities:  

Year:  2011        PMID： 21857834      PMCID： PMC3127038     

Source DB:  PubMed          Journal:  Gastroenterol Hepatol (N Y)        ISSN： 1554-7914


× No keyword cloud information.
  6 in total

1.  Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trial.

Authors:  Geert D'Haens; Filip Baert; Gert van Assche; Philip Caenepeel; Philippe Vergauwe; Hans Tuynman; Martine De Vos; Sander van Deventer; Larry Stitt; Allan Donner; Severine Vermeire; Frank J Van De Mierop; Jean-Charles R Coche; Janneke van der Woude; Thomas Ochsenkühn; Ad A van Bodegraven; Philippe P Van Hootegem; Guy L Lambrecht; Fazia Mana; Paul Rutgeerts; Brian G Feagan; Daniel Hommes
Journal:  Lancet       Date:  2008-02-23       Impact factor: 79.321

2.  Early Crohn disease: a proposed definition for use in disease-modification trials.

Authors:  Laurent Peyrin-Biroulet; Edward V Loftus; Jean-Frederic Colombel; William J Sandborn
Journal:  Gut       Date:  2010-02       Impact factor: 23.059

3.  Infliximab, azathioprine, or combination therapy for Crohn's disease.

Authors:  Jean Frédéric Colombel; William J Sandborn; Walter Reinisch; Gerassimos J Mantzaris; Asher Kornbluth; Daniel Rachmilewitz; Simon Lichtiger; Geert D'Haens; Robert H Diamond; Delma L Broussard; Kezhen L Tang; C Janneke van der Woude; Paul Rutgeerts
Journal:  N Engl J Med       Date:  2010-04-15       Impact factor: 91.245

4.  Increased response and remission rates in short-duration Crohn's disease with subcutaneous certolizumab pegol: an analysis of PRECiSE 2 randomized maintenance trial data.

Authors:  Stefan Schreiber; Jean-Frédéric Colombel; Ralph Bloomfield; Susanna Nikolaus; Jürgen Schölmerich; Julian Panés; William J Sandborn
Journal:  Am J Gastroenterol       Date:  2010-03-16       Impact factor: 10.864

5.  Disability in inflammatory bowel diseases: developing ICF Core Sets for patients with inflammatory bowel diseases based on the International Classification of Functioning, Disability, and Health.

Authors:  Laurent Peyrin-Biroulet; Alarcos Cieza; William J Sandborn; Nenad Kostanjsek; Michael A Kamm; Toshifumi Hibi; Marc Lémann; Gerold Stucki; Jean-Frédéric Colombel
Journal:  Inflamm Bowel Dis       Date:  2010-01       Impact factor: 5.325

6.  Development of the Crohn's disease digestive damage score, the Lémann score.

Authors:  Benjamin Pariente; Jacques Cosnes; Silvio Danese; William J Sandborn; Maïté Lewin; Joel G Fletcher; Yehuda Chowers; Geert D'Haens; Brian G Feagan; Toshifumi Hibi; Daniel W Hommes; E Jan Irvine; Michael A Kamm; Edward V Loftus; Edouard Louis; Pierre Michetti; Pia Munkholm; Tom Oresland; Julian Panés; Laurent Peyrin-Biroulet; Walter Reinisch; Bruce E Sands; Juergen Schoelmerich; Stefan Schreiber; Herbert Tilg; Simon Travis; Gert van Assche; Maurizio Vecchi; Jean-Yves Mary; Jean-Frédéric Colombel; Marc Lémann
Journal:  Inflamm Bowel Dis       Date:  2010-11-28       Impact factor: 5.325
  6 in total
  4 in total

1.  Systematic review and meta-analysis: efficacy and safety of early biologic treatment in adult and paediatric patients with Crohn's disease.

Authors:  Ryan C Ungaro; Saurabh Aggarwal; Ozlem Topaloglu; Wan-Ju Lee; Ryan Clark; Jean-Frederic Colombel
Journal:  Aliment Pharmacol Ther       Date:  2020-03-23       Impact factor: 8.171

2.  Enteroscopy in Crohn's Disease: Are There Any Changes in Role or Outcomes Over Time? A KASID Multicenter Study.

Authors:  Seong Ran Jeon; Jin-Oh Kim; Jeong-Sik Byeon; Dong-Hoon Yang; Bong Min Ko; Hyeon Jeong Goong; Hyun Joo Jang; Soo Jung Park; Eun Ran Kim; Sung Noh Hong; Jong Pil Im; Seong-Eun Kim; Ja Seol Koo; Chang Soo Eun; Dong Kyung Chang
Journal:  Gut Liver       Date:  2021-05-15       Impact factor: 4.519

Review 3.  Exploring the Early Phase of Crohn's Disease.

Authors:  Giorgos Bamias; Fabio Cominelli
Journal:  Clin Gastroenterol Hepatol       Date:  2020-09-16       Impact factor: 13.576

Review 4.  Role of B-Cell Activating Factor (BAFF) in Inflammatory Bowel Disease.

Authors:  Marko Kumric; Piero Marin Zivkovic; Tina Ticinovic Kurir; Josip Vrdoljak; Marino Vilovic; Dinko Martinovic; Andre Bratanic; Ivan Kresimir Lizatovic; Josko Bozic
Journal:  Diagnostics (Basel)       Date:  2021-12-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.